Skip to main content

Table 3 mRNA expression level of several markers associates with neuroblastoma risk factors, prognostic groups and survival

From: Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Grouping variable Statistics CNR1 GRB10 KRT19 PRPH QPCT
Stage Kruskal-Wallis P-value <0.001 0.008 0.118 0.010 <0.001
MYCN Mann-Whitney P-value <0.001 <0.001 <0.001 <0.001 <0.001
Age cutoff 12 months Mann-Whitney P-value <0.001 0.609 <0.001 0.005 <0.001
Age cutoff 18 months Mann-Whitney P-value <0.001 0.810 <0.001 0.003 0.006
Overall survival status Mann-Whitney P-value <0.001 0.003 0.023 <0.001 <0.001
Prognostic group Kruskal-Wallis P-value <0.001 0.002 0.005 <0.001 <0.001
  1. The statistical test used is shown and P-values (corrected for multiple testing using Benjamini-Hochberg) are indicated. P-values in bold indicate significant associations.